Manufacturer
Novartis NDC Codes
Finished products listed with the FDA under labeler names that contain “Novartis”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Simulectbasiliximab | Basiliximab 20 mg/5mL | Injection, Powder, For solutionIntravenous | Novartis Pharmaceuticals Corporation | 0078-0331 |
| Simulectbasiliximab | Basiliximab 10 mg/2.5mL | Injection, Powder, For solutionIntravenous | Novartis Pharmaceuticals Corporation | 0078-0393 |
| Tabrectacapmatinib | Capmatinib hydrochloride 150 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0709 |
| Tabrectacapmatinib | Capmatinib hydrochloride 200 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0716 |
| Tafinlardabrafenib | Dabrafenib mesylate 75 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0681 |
| Tafinlardabrafenib | Dabrafenib mesylate 50 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0682 |
| Tafinlardabrafenib | Dabrafenib mesylate 10 mg/1 | Tablet, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-1154 |
| Tasignanilotinib | Nilotinib hydrochloride monohydrate 200 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0526 |
| Tasignanilotinib | Nilotinib hydrochloride monohydrate 150 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0592 |
| Tasignanilotinib | Nilotinib hydrochloride monohydrate 50 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0951 |
| Tegretolcarbamazepine | Carbamazepine 100 mg/5mL | SuspensionOral | Novartis Pharmaceuticals Corporation | 0078-0508 |
| Tegretolcarbamazepine | Carbamazepine 200 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0509 |
| Tegretol XRcarbamazepine | Carbamazepine 100 mg/1 | Tablet, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0510 |
| Tegretol XRcarbamazepine | Carbamazepine 200 mg/1 | Tablet, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0511 |
| Tegretol XRcarbamazepine | Carbamazepine 400 mg/1 | Tablet, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0512 |
| TobraDextobramycin and dexamethasone | Tobramycin 3 mg/g; Dexamethasone 1 mg/g | OintmentOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0876 |
| Tobrextobramycin | Tobramycin 3 mg/g | OintmentOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0813 |
| Travatan Ztravoprost | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0946 |
| Triesencetriamcinolone acetonide | Triamcinolone acetonide 40 mg/mL | Injection, SuspensionOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0897 |
| Trileptaloxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0337 |
| Trileptaloxcarbazepine | Oxcarbazepine 60 mg/mL | SuspensionOral | Novartis Pharmaceuticals Corporation | 0078-0357 |
| Trileptaloxcarbazepine | Oxcarbazepine 150 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0456 |
| Trileptaloxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0457 |
| Tykerblapatinib | Lapatinib ditosylate 250 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0671 |
| Vanrafiaatrasentan | Atrasentan hydrochloride .75 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-1420 |